| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.02B | 28.40B | 25.72B | 22.06B | 20.90B | 19.53B |
| Gross Profit | 20.66B | 20.19B | 17.83B | 12.87B | 11.69B | 11.12B |
| EBITDA | 3.94B | 3.73B | 2.88B | 2.13B | 2.31B | 2.28B |
| Net Income | 2.10B | 1.95B | 1.41B | 722.79M | 474.10M | 310.58M |
Balance Sheet | ||||||
| Total Assets | 43.68B | 43.48B | 43.00B | 42.66B | 39.06B | 38.43B |
| Cash, Cash Equivalents and Short-Term Investments | 4.14B | 4.10B | 3.59B | 5.22B | 3.45B | 4.31B |
| Total Debt | 14.80B | 15.20B | 15.28B | 17.79B | 17.32B | 18.91B |
| Total Liabilities | 27.25B | 27.30B | 28.34B | 29.14B | 25.38B | 25.03B |
| Stockholders Equity | 16.42B | 16.17B | 14.64B | 13.50B | 13.46B | 13.36B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.14B | 2.38B | 243.90M | 1.64B | 3.68B |
| Operating Cash Flow | 0.00 | 4.14B | 3.61B | 1.42B | 2.29B | 6.09B |
| Investing Cash Flow | 0.00 | -2.01B | -1.28B | 1.26B | -1.71B | -2.54B |
| Financing Cash Flow | 0.00 | -1.62B | -3.96B | -908.99M | -1.44B | -2.12B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥47.21B | 3.67 | ― | ― | 8.03% | 13.35% | |
71 Outperform | ¥42.72B | 6.30 | ― | 1.42% | 10.96% | 75.10% | |
69 Neutral | ¥41.25B | 35.22 | ― | 1.35% | 11.02% | -0.61% | |
66 Neutral | ¥22.60B | 7.10 | ― | 0.76% | 20.69% | 17.46% | |
63 Neutral | ¥400.79B | 21.16 | 10.65% | 1.64% | 14.75% | 22.10% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | ¥6.32B | 12.92 | ― | 2.41% | <0.01% | 23.81% |